Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention.
Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER, Slingerland JM.
CA Cancer J Clin. 2017 Sep;67(5):378-397. doi: 10.3322/caac.21405. Epub 2017 Aug 1.
PMID:28763097
Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index: A Secondary Analysis of a Randomized Clinical Trial and Observational Study.
Iyengar NM, Arthur R, Manson JE, Chlebowski RT, Kroenke CH, Peterson L, Cheng TD, Feliciano EC, Lane D, Luo J, Nassir R, Pan K, Wassertheil-Smoller S, Kamensky V, Rohan TE, Dannenberg AJ.
JAMA Oncol. 2019 Feb 1;5(2):155-163. doi: 10.1001/jamaoncol.2018.5327.
PMID:30520976
Body mass index and risk of inflammatory breast disease: a Mendelian randomization study.
Wei C, Wang X, Zeng J, Zhang G.
Nutr Hosp. 2024 Feb 15;41(1):96-111. doi: 10.20960/nh.04746.
PMID:37522462
Benign Breast Disorders.
Weaver M, Stuckey A.
Obstet Gynecol Clin North Am. 2022 Mar;49(1):57-72. doi: 10.1016/j.ogc.2021.11.003.
PMID:35168773
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update.
Roskoski R Jr.
Pharmacol Res. 2024 Feb;200:107059. doi: 10.1016/j.phrs.2024.107059. Epub 2024 Jan 11.